ロード中...
Low-Dose Electron Beam Radiation and Romidepsin Therapy for Symptomatic Cutaneous T-Cell Lymphoma Lesions
BACKGROUND: Romidepsin is a structurally unique histone deacetylase inhibitor FDA-approved for therapy of relapsed or refractory cutaneous T-cell lymphoma (CTCL). Localized electron beam radiation therapy (LEBT) is standard practice in the care of patients with chronically traumatized and painful le...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3386371/ https://ncbi.nlm.nih.gov/pubmed/22372971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2133.2012.10905.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|